Drug Resistance in Leishmaniasis

By Simon L. Croft, S. Sundar, Alan H. Fairlamb. Clinical Microbiology Reviews, 2006

1,823 citations recorded by the source corpus.

Subfields: Epidemiology, Parasitology, Public Health, Environmental and Occupational Health

View Paper: https://www.semanticscholar.org/paper/7c51ad5df96fa3e2a97ebeb4a0ead05ca5069fbe

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Public Health, Environmental and Occupational Health

1. J. Alvar
2. L. Gradoni

Citations in the corpus

• The Relationship between Leishmaniasis and AIDS: the Second 10 Years (2008, background): “After a decade of use, the efficacy has declined to 70% (67).”
• Directions for the diagnosis, clinical staging, treatment and prevention of canine leishmaniosis. (2009, background): “and miltefosine is well known in human medicine (Croft et al., 2006), only limited information is available for the dog.”
• Canine leishmaniosis - new concepts and insights on an expanding zoonosis: part one. (2008, positive): “The zoonotic potential of CanL, lack of a parasitological cure, and the reported occurrence of parasitic resistance to pentavalent antimonials, amphotericin B, aminosidine and miltefosine [ 31 ] indicate that it would be best to avoid or minimize the use of the same drugs for therapy of CanL and hum”